全文获取类型
收费全文 | 117013篇 |
免费 | 11718篇 |
国内免费 | 7445篇 |
专业分类
耳鼻咽喉 | 1182篇 |
儿科学 | 1606篇 |
妇产科学 | 1625篇 |
基础医学 | 12111篇 |
口腔科学 | 2363篇 |
临床医学 | 14119篇 |
内科学 | 16703篇 |
皮肤病学 | 1223篇 |
神经病学 | 5043篇 |
特种医学 | 4672篇 |
外国民族医学 | 54篇 |
外科学 | 12666篇 |
综合类 | 21588篇 |
现状与发展 | 27篇 |
一般理论 | 18篇 |
预防医学 | 8834篇 |
眼科学 | 2679篇 |
药学 | 13295篇 |
141篇 | |
中国医学 | 7429篇 |
肿瘤学 | 8798篇 |
出版年
2024年 | 483篇 |
2023年 | 1897篇 |
2022年 | 4684篇 |
2021年 | 6060篇 |
2020年 | 4579篇 |
2019年 | 3672篇 |
2018年 | 3881篇 |
2017年 | 3677篇 |
2016年 | 3478篇 |
2015年 | 5274篇 |
2014年 | 6505篇 |
2013年 | 6612篇 |
2012年 | 9296篇 |
2011年 | 9777篇 |
2010年 | 7020篇 |
2009年 | 5846篇 |
2008年 | 6885篇 |
2007年 | 6910篇 |
2006年 | 6286篇 |
2005年 | 5507篇 |
2004年 | 4424篇 |
2003年 | 4046篇 |
2002年 | 3578篇 |
2001年 | 2824篇 |
2000年 | 2444篇 |
1999年 | 1975篇 |
1998年 | 1079篇 |
1997年 | 1083篇 |
1996年 | 844篇 |
1995年 | 710篇 |
1994年 | 632篇 |
1993年 | 411篇 |
1992年 | 593篇 |
1991年 | 479篇 |
1990年 | 468篇 |
1989年 | 394篇 |
1988年 | 313篇 |
1987年 | 294篇 |
1986年 | 230篇 |
1985年 | 172篇 |
1984年 | 130篇 |
1983年 | 91篇 |
1982年 | 60篇 |
1981年 | 76篇 |
1980年 | 41篇 |
1979年 | 73篇 |
1978年 | 37篇 |
1974年 | 36篇 |
1973年 | 33篇 |
1972年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
Delta hepatitis virus infection in China 总被引:1,自引:0,他引:1
D Q Wang H H Cheng G Y Minuk L H Liu C M Anand T C Stowe H X Wang D C Ying Y R Tu K A Buchan 《International journal of epidemiology》1987,16(1):79-83
To assess the prevalence, epidemiological features and prognostic implications of hepatitis D (Delta) in Sichuan Province, The People's Republic of China, 649 sera (515 from HBsAg positive patients and 134 from HBsAg negative subjects) were tested by radioimmunoassay (RIA) for antibody to the hepatitis D virus (anti-HD). Forty-seven sera (7.2%) showed some degree of reactivity. Serial dilutions of these sera indicated that prozoning was not responsible for the equivocal results. Thirty-four of the 47 sera were submitted under code to a second laboratory for independent analysis. According to those results anti-HD antibodies were detected in four of these sera. The overall prevalence of anti-HD in the HBsAg positive patients therefore was 0.8% (4/515). On the basis of clinical, biochemical and histological data 427 HBsAg positive sera were further divided into acute Type B hepatitis, chronic Type B hepatitis, healthy carrier state and hepatocellular carcinoma (HCC) subgroups. Two of 65 (3.1%) anti-HD positive sera belonged to the acute Type B hepatitis group; one of 104 (0.9%), the chronic Type B hepatitis group and one of 246 (0.4%), the healthy carrier group. No antibody was detected in sera from 12 HBsAg positive HCC patients. All HBsAg negative patients were negative for anti-HD antibody. The results of this study indicate that despite a high prevalence of hepatitis B virus infection, positive serology for delta virus is uncommon in Sichuan Province, The People's Republic of China. 相似文献
52.
HPLC法测定欣康胶囊中次乌头碱含量 总被引:3,自引:0,他引:3
目的测定欣康胶囊中次乌头碱的含量。方法采用反相高效液相法,以C18为固定相,甲醇-水-三乙胺(75∶25∶0.05)为流动相,检测波长为232nm。结果平均回收率为94.65%,RSD为3.54%。结论方法简便,准确。 相似文献
53.
脊柱复合性损伤的救治风险与早期治疗 总被引:3,自引:1,他引:2
目的评估脊柱复合性损伤的特点和救治风险,探讨风险控制与最佳治疗的方法。方法采用AIS、ISS、TRISS及APACHEⅡ等评分方法对273例脊柱复合性损伤患者进行定量评价与救治分类,并依据伤后的损伤分级、参数评定及计量评分等指标进行量化分析和统计处理。结果颈椎合并伤115例,胸椎合并伤141例,胸腰椎合并伤294例,腰骶椎合并伤181例;患者的救治风险和脊椎伤的治疗选择或手术时机与其合并伤的解剖伤势及由此所构成的整体伤情密切相关(P<0.01或<0.05);高风险性伤员往往综合伤势严重,生存概率(Ps)趋低,并发症和死亡率高(P<0.01或<0.05)。结论脊柱脊髓损伤常合并有严重的多发伤,高危伤情不仅可增加其救治风险和脊柱伤的处理难度,且还易于丧失手术最佳时机。分类救治对伤员的风险控制和脊柱伤的专科治疗是有益的。 相似文献
54.
The antiparasitic drug, suramin, has antiproliferative effects in human carcinoma cells. It has been suggested that this occurs through blockade of growth factor-receptor interactions. Three types of evidence that suramin rapidly inhibits cellular respiration or disrupts cellular energy balance in intact cells of the human prostate carcinoma cell line, DU145, are presented. Beginning at approximately 10(-4) M, suramin rapidly causes dose-dependent inhibition of tetrazolium conversion by mitochondrial dehydrogenases in intact cells, demonstrating an inhibition of respiration. This effect is reversed by exchange with suramin-free media but not by pretreatment with serum, epidermal growth factor, insulin-like growth factor I, acidic and basic fibroblast growth factors, or calcium. Rhodamine 123 (10 micrograms/ml) uptake by mitochondria in intact DU145 cells is inhibited in the presence of 10(-3) M suramin. Treatment with 10(-4)-10(-3) M suramin causes the loss of rhodamine 123 from cells with mitochondria prestained with rhodamine 123, indicating that suramin is acting as an ionophore or respiratory poison. Also shown by electron microscopy are progressive toxic changes in mitochondria of DU145 cells within 1 h after treatment with 10(-4) M suramin. These data indicate that in intact DU145 cells 10(-4) M suramin rapidly disrupts cellular energy balance or respiration as seen by three studies of mitochondrial state. Disruption of energy balance or respiration represents a likely antiproliferative mechanism, as is thought to be a primary mechanism for the action of suramin in parasitic diseases. This proposed mechanism of action for suramin can explain the most prominent observed clinical toxicities of nephrotoxicity, adrenal toxicity, coagulopathy, and demyelinating neuropathy. 相似文献
55.
56.
57.
John Jenn-Yenn Lu Chi-Chia Cheng Shieu-Ming Chou Chang-Bor Hor Yi-Chen Yang Hsiang-Ling Wang 《Vaccine》2009
The first universal hepatitis B vaccination program for newborns in the world was launched in Taiwan in July 1984. Most studies on the effectiveness of hepatitis B vaccination focused on the seroprevalence of HBs Ag among children under 14 years old. Only few studies focused on the seropositivity of anti-HBs among adolescents aged 15–18 years old. The present study aimed to evaluate the impact of the nationwide hepatitis B vaccination program on the immunity to HBV infection and the necessity of boost among adolescents. In this study including eight annual seroprevalence surveys from 2000 to 2007, 2342 college entrants (1589 15-year-olds in group I and 753 18-year-olds in group II) and 1851 university freshmen (18-year-olds in group III) participated. Subjects identified anti-HBs, HBs Ag and anti-HBc negative were given boost three doses of HBV vaccine. The HBs Ag seroprevalence was 11.6%, 3.5% and 1.0% for participants who were born before 1984, 1984–1986 and after 1986. The anti-HBs-seropositive rates were significantly higher in group II (83.1%) than in group I (53.0%) and group III (53.5%). All 572 participants who were seronegative for anti-HBs, HBs Ag and anti-HBc became anti-HBs-seropositive after catch-up vaccination. It is concluded that the anti-HBs-seropositive rate decreased to 50% in 15 years after vaccination, and boost vaccination was 100% effective. The necessity and age for boost among anti-HBs negative adolescents and the timing of the first immunization should be further evaluated. 相似文献
58.
Background The incidence rate of incisional hernias after open surgery has been reported to be higher than that of port site hernias
after laparoscopic surgery. No studies have compared the costs for the health care system in treating those two types of hernia.
Methods A systematic review was conducted to obtain the baseline data, and a decision analysis model was created to simulate the occurrence
and recurrence of incisional and port site hernias.
Results The overall risk of having incisional hernias was eight-times higher than that of having port site hernias (7.4% vs 0.9%).
A cost savings of £93 per patient can be generated for the health care system in the UK. Similar results were obtained for
Germany, Italy and France.
Conclusions The additional treatment costs for incisional hernia should be taken into account when the costs of a surgery performed by
open approach are compared with by laparoscopy. 相似文献
59.
60.
现代医学200词——138.黏附分子 总被引:1,自引:0,他引:1
所谓黏附分子是指存在于细胞表面,参与细胞间或细胞与细胞外基质的粘附的分子群的总称。广义来说,纤维连结蛋白、层粘连蛋白、透明质酸等细胞外基质的构成成分也是由细胞分泌并存在于细胞表面,也可归入黏附分子的范畴。但狭义所指的黏附分子是指贯通细胞膜的糖蛋白或构成细胞膜的糖脂质。膜贯通型糖蛋白黏附分子按其构造特征可分为若干家族。在免疫系统中的黏附分子主要分为整合素家族、免疫球蛋白超家族、选择素家族、钙粘素家族、连接蛋白家族以及唾液粘蛋白家族等。 相似文献